Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

689 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proton beam therapy for children and adolescents and young adults (AYAs): JASTRO and JSPHO Guidelines.
Mizumoto M, Fuji H, Miyachi M, Soejima T, Yamamoto T, Aibe N, Demizu Y, Iwata H, Hashimoto T, Motegi A, Kawamura A, Terashima K, Fukushima T, Nakao T, Takada A, Sumi M, Oshima J, Moriwaki K, Nozaki M, Ishida Y, Kosaka Y, Ae K, Hosono A, Harada H, Ogo E, Akimoto T, Saito T, Fukushima H, Suzuki R, Takahashi M, Matsuo T, Matsumura A, Masaki H, Hosoi H, Shigematsu N, Sakurai H. Mizumoto M, et al. Among authors: kosaka y. Cancer Treat Rev. 2021 Jul;98:102209. doi: 10.1016/j.ctrv.2021.102209. Epub 2021 Apr 16. Cancer Treat Rev. 2021. PMID: 33984606 Free article. Review.
Medulloblastoma with suprasellar solitary massive metastasis: Case report.
Nagashima H, Nagashima T, Kawamura A, Yamamoto K, Yoshida M, Hasegawa D, Kosaka Y, Kohmura E. Nagashima H, et al. Among authors: kosaka y. Neurol Neurochir Pol. 2016;50(3):211-4. doi: 10.1016/j.pjnns.2016.02.001. Epub 2016 Feb 18. Neurol Neurochir Pol. 2016. PMID: 27154451
Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia.
Nakayama H, Tomizawa D, Tanaka S, Iwamoto S, Shimada A, Saito AM, Yamashita Y, Moritake H, Terui K, Taga T, Matsuo H, Kosaka Y, Koh K, Hosoi H, Kurosawa H, Isoyama K, Horibe K, Mizutani S, Adachi S. Nakayama H, et al. Among authors: kosaka y. Pediatr Int. 2017 Oct;59(10):1046-1052. doi: 10.1111/ped.13378. Pediatr Int. 2017. PMID: 28771903 Clinical Trial.
Disordered hemostasis associated with severely depressed fibrinolysis demonstrated using a simultaneous thrombin and plasmin generation assay during L-asparaginase induction therapy in pediatric acute lymphoblastic leukemia.
Ishihara T, Nogami K, Ochi S, Ishida T, Kosaka Y, Sawada A, Inoue M, Osone S, Imamura T, Hosoi H, Shima M. Ishihara T, et al. Among authors: kosaka y. Pediatr Blood Cancer. 2020 Jan;67(1):e28016. doi: 10.1002/pbc.28016. Epub 2019 Sep 25. Pediatr Blood Cancer. 2020. PMID: 31556233
Clinical characteristics, treatment, and survival outcome in pediatric patients with atypical teratoid/rhabdoid tumors: a retrospective study by the Japan Children's Cancer Group.
Yamasaki K, Kiyotani C, Terashima K, Watanabe Y, Kanamori M, Koga Y, Hata N, Iwasaki F, Goto H, Koh K, Kurihara J, Tokunaga S, Arakawa Y, Hasegawa D, Kosaka Y, Hara J. Yamasaki K, et al. Among authors: kosaka y. J Neurosurg Pediatr. 2019 Nov 15:1-10. doi: 10.3171/2019.9.PEDS19367. Online ahead of print. J Neurosurg Pediatr. 2019. PMID: 31731266
The comparison of acute toxicities associated with craniospinal irradiation between photon beam therapy and proton beam therapy in children with brain tumors.
Uemura S, Demizu Y, Hasegawa D, Fujikawa T, Inoue S, Nishimura A, Tojyo R, Nakamura S, Kozaki A, Saito A, Kishimoto K, Ishida T, Mori T, Koyama J, Kawamura A, Akasaka Y, Yoshida M, Fukumitsu N, Soejima T, Kosaka Y. Uemura S, et al. Among authors: kosaka y. Cancer Med. 2022 Mar;11(6):1502-1510. doi: 10.1002/cam4.4553. Epub 2022 Feb 9. Cancer Med. 2022. PMID: 35137555 Free PMC article.
Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group.
Sato A, Hatta Y, Imai C, Oshima K, Okamoto Y, Deguchi T, Hashii Y, Fukushima T, Hori T, Kiyokawa N, Kato M, Saito S, Anami K, Sakamoto T, Kosaka Y, Suenobu S, Imamura T, Kada A, Saito AM, Manabe A, Kiyoi H, Matsumura I, Koh K, Watanabe A, Miyazaki Y, Horibe K. Sato A, et al. Among authors: kosaka y. Lancet Haematol. 2023 Jun;10(6):e419-e432. doi: 10.1016/S2352-3026(23)00072-8. Epub 2023 May 8. Lancet Haematol. 2023. PMID: 37167992 Clinical Trial.
689 results